Leaders in Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.


Two Pharma Firms in India Begin Phase IV Efficacy Trial for COVID-19 Drug, an Industrial Info Market Brief

Free News Article
India COVID drug 0920
Attachment Included

India's Central Drugs Standard Control Organisation (CDSCO) recently granted approval to pharmaceutical majors Cipla Limited and Optimus Pharma Limited to conduct Phase IV trials for Favipiravir, the most sought-after medicine in the treatment of mild to moderate symptoms of COVID-19.

Details on this Article:
Industry Segment: Market Brief
Word Count: 162 Words
Attachment: India COVID drug 0920
Listen to Today's News News Audio Library Sync News Podcasts

Login or Register now for instant access!
Related Articles


This article is free for all Registered Members.

Register Now! All Fields are Required...

Pricing Help?

Upgrade your Premium News Subscription to include all archived articles for only $160. Contact Member Services: 800-762-3361

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • North American Plant Analysis by Industry & Market Region
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current & Historic Economic Indicators
  • 30/60/90 Day Weather Forecast